The Rejuvenation of ImmuCell Corporation (NASDAQ:ICCC)

The Rejuvenation of ImmuCell Corporation (NASDAQ:ICCC)

SHARE

The ImmuCell Corporation (ICCC) shares are trading at higher $4.73.

To add more color to this target, the company’s high over the last year is $8.13 and the low is $3.70. Over the last 52 weeks, ICCC is down -41.76% while the S&P 500 is up 1.07%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, ICCC reported a profit of $2.24 million. ImmuCell Corporation also saw revenues increase to $4.91 million. In addition, ICCC has free cash flow of -$0.4 million as of 03-2020 The company’s EBITDA came in at $0.85 million which compares well with its peers.

ICCC booked profit margins of -11.00%, its Return on Equity (ROE) is -5.40%, and its Return on Assets is -4.00%. All told, it is clear that, ICCC needs to be on your watchlist.

Find out when ICCC reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. ICCC has a short ratio of 0.05 and outstanding shares of 7.21M.

Company Outlook

ICCC has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 16640.0 and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -0.22. ImmuCell Corporation ICCC also noted assets of $40.05 million at the end of the last quarter. Investors should also keep an eye on sector updates as ICCC has historically followed its peers on positive news.

All told, ImmuCell Corporation ICCC has strung together solid data and demonstrated underlying fundamentals. At its current valuation, ICCC represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

ImmuCell Corporation ICCC is now commanding a market cap of 35.32M and a float of 5.14M. ICCC is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of ICCC stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in ICCC, either long or short, and we have not been compensated for this article.